Table 2.
Neurocognitive functioning- social cognitive functioning | Psychiatric symptoms | A Estimate (P-value) | B Estimate (P-value) | C Estimate (P-value) | C’ Estimate (P-value) | Indirect effect (Lower limit 95% CI, upper limit 95% CI) | Effect size of the indirect effect | Controlling for education, age and sex | A Estimate (P-value) | B Estimate (P-value) | C Estimate (P-value) | C’ Estimate (P-value) | Indirect effect (Lower limit 95% CI, upper limit 95% CI) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Perception- ToM |
Negative symptoms |
0.36** (0.0053) |
-0.99* (0.0227) |
-0.97* (0.0201) |
-0.62 (0.1469) |
-0.3553 (-0.9668, -0.0480) |
0.0603 |
|
0.33* (0.0274) |
-0.97* (0.0302) |
-1.03* (0.0334) |
-0.71 (0.1399) |
-0.3159 (-1.0705, -0.0077) |
Executive functioning - ToM |
|
0.26* (0.0200) |
-1.03* (0.0159) |
-0.78* (0.0290) |
-0.52 (0.1464) |
-0.2667 (-0.6880, -0.0518) |
0.0498 |
|
0.23* (0.0405) |
-0.99* (0.0266) |
-0.76* (0.0405) |
-0.53 (0.1491) |
-0.2279 (-0.6625, -0.0149) |
Perception- ToM |
Positive symptoms |
0.36** (0.0053) |
-0.62* (0.0520) |
-0.14 (0.6448) |
0.08 (0.7849) |
-0.2199 (-0.6595, -0.0223) |
0.0026 |
|
0.33* (0.0274) |
-0.64* (0.0530) |
-0.20 (0.5676) |
0.01 (0.9804) |
-0.2071 (-0.7150, 0.0044) |
Executive functioning - ToM |
|
0.26* (0.0200) |
-0.49 (0.1097) |
-0.39 (0.1158) |
-0.27 (0.2991) |
-0.1261 (-0.3579, -0.0118) |
0.0254 |
|
0.23* (0.0405) |
-0.54 (0.0947) |
-0.42 (0.1129) |
-0.29 (0.2743) |
-0.1238 (-0.3888, -0.0027) |
Perception – ToM |
General symptoms |
0.36** (0.0053) |
-0.55 (0.1300) |
-0.53 (0.1256) |
-0.32 (0.3659) |
-0.1978 (-0.6631, 0.0324) |
0.0275 |
|
0.33* (0.0274) |
-0.53 (0.1554) |
-0.65 (0.1030) |
-0.47 (0.2469) |
-0.1735 (-0.7176, 0.0364) |
Executive functioning - ToM | 0.26* (0.0200) | -0.46 (0.1797) | -0.69* (0.0162) | -0.57* (0.0545) | -0.1204 (-0.3798, 0.0361) | 0.0377 | 0.23* (0.0405) | -0.46 (0.2045) | -0.71* (0.0169) | -0.60* (0.0477) | -0.1061 (-0.4127, 0.0351) |
Note: (A) Regression slope of neurocognitive functioning predicting social cognitive functioning; (B) regression slope of social cognitive functioning predicting psychiatric symptoms, controlling for neurocognitive functioning; (C) regression slope of neurocognitive functioning predicting psychiatric symptoms; (C’) regression slope of neurocognitive functioning predicting psychiatric symptoms, controlling for social cognitive functioning. Bootstrapping was used to estimate indirect effects (Shrout & Bolger, 2002).
*P < = 0.05.
**P < =0.01.